ArticleProceedings of the National Academy of Sciences of the United States of America2020

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.

Xiaoling Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.